| __timestamp | Arrowhead Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 22570000 |
| Thursday, January 1, 2015 | 34718089 | 24378000 |
| Friday, January 1, 2016 | 40998209 | 26621000 |
| Sunday, January 1, 2017 | 32022880 | 28653000 |
| Monday, January 1, 2018 | 19110051 | 37734000 |
| Tuesday, January 1, 2019 | 26556257 | 41884000 |
| Wednesday, January 1, 2020 | 52275890 | 64435000 |
| Friday, January 1, 2021 | 80981000 | 57483000 |
| Saturday, January 1, 2022 | 124431000 | 70062000 |
| Sunday, January 1, 2023 | 90932000 | 52790000 |
| Monday, January 1, 2024 | 98761000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Arrowhead Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Over this period, Arrowhead's SG&A expenses surged by approximately 300%, peaking in 2022. In contrast, Ligand's expenses grew by about 210%, with a notable peak in 2022 as well.
The data highlights the dynamic nature of the pharmaceutical sector, where strategic financial management is pivotal for sustained growth.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Biogen Inc. and Ligand Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Arrowhead Pharmaceuticals, Inc.
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Grifols, S.A. and Arrowhead Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Ligand Pharmaceuticals Incorporated
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation
Comparing SG&A Expenses: Ligand Pharmaceuticals Incorporated vs Iovance Biotherapeutics, Inc. Trends and Insights